Information  X 
Enter a valid email address
  Print          More announcements

Wednesday 11 May, 2022

Goldman Sachs & Co.

Form 38.5b - Hibernia Reit plc

RNS Number : 1247L
Goldman Sachs & Co. LLC
11 May 2022
 

 

FORM 38.5(b)

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNISED INTERMEDIARY STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

 

1. KEY INFORMATION

 

Name of exempt principal trader

GOLDMAN SACHS & CO. LLC

Company dealt in

HIBERNIA REIT PLC

Class of relevant security to which the dealings being disclosed relate (Note1)

EUR 0.10 ordinary shares

Date of dealing

10 May 2022

 

2. INTERESTS AND SHORT POSITIONS

 

(a) Interests and short positions (following dealing) in the class of relevant security dealt in  (Note 2)

 


Long

Short


Number

(%)

Number

(%)

(1) Relevant securities

15,352

(0.00)

7,697

(0.00)

(2) Derivatives (other than options)

0

(0.00)

0

(0.00)

(3) Options and agreements to purchase/sell

0

(0.00)

0

(0.00)

Total

15,352

(0.00)

7,697

(0.00)

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in  (Note 2)

 

Class of relevant security:

Long

Short


Number

(%)

Number

(%)

(1) Relevant securities





(2) Derivatives (other than options)





(3) Options and agreements to purchase/sell





Total





 

3.  DEALINGS (Note 3)

(a) Purchases and sales

 

Purchase/sale

Number of relevant securities

Price per unit  (Note 4)

Sale (Borrow Partial Return)

1,210

N/A

Purchase (Borrow New)

1,119

N/A

 

(b) Derivatives transactions (other than options transactions)

 

Product name, e.g. CFD

Nature of transaction  (Note 5)

Number of relevant securities  (Note 6)

Price per unit  (Note 4)





 

(c) Options transactions in respect of existing relevant securities

 

(i) Writing, selling, purchasing or varying

 

Product name,e.g. call option

Writing, selling,  purchasing, varying etc.

Number of securities to which the option relates  (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit  (Note 4)








 

(ii)  Exercising

 

Product name,e.g. call option

Number of securities

Exercise price per unit  (Note 4)




 

(d)  Other dealings (including transactions in respect of new securities)  (Note 3)

 

Nature of transaction  (Note 7)

Details

Price per unit (if applicable)  (Note 4)




 

4. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.  If none, this should be stated. 

NONE

 

Is a Supplemental Form 8 attached? (Note 9)  NO

 

Date of disclosure

11 May 2022

Contact name

Papa Lette and Andrzej Szyszka

Telephone number

+33(1) 4212 1459 / +48(22) 317 4817

Name of offeree/offeror with which connected

BENEDICT REAL ESTATE BIDCO LIMITED, A SUBSIDIARY OF ONE OF BROOKFIELD ASSET MANAGEMENT'S REAL ESTATE PRIVATE FUNDS.

Nature of connection (Note 9)

Advisor to Offeree

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ISEEAESFFLDAEFA

a d v e r t i s e m e n t